Park Medi World Q3 FY26 Revenue Up 18% to ₹410 Crore; Acquires 560 Beds
Park Medi World reported Q3 FY26 revenue of ₹410 crore, an 18% YoY increase. 9M FY26 revenue grew 17% to ₹1,218.9 crore. PAT for 9M FY26 rose 43% to ₹196.8 crore. The company acquired 560 beds through Febris Hospital and KP Institute of Medical Sciences, strengthening its North India footprint.
The announcement includes substantial financial growth and significant strategic acquisitions that are expected to drive future growth and market position.
The company reported strong revenue growth, significant profit increase, and strategic acquisitions that expand its capacity and market presence.
Park Medi World Limited announced its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The company reported a strong year-on-year revenue growth of approximately 18% in Q3 FY26, reaching ₹410 crore (₹4,100 million). For the nine-month period of FY26, revenue grew by 17% to ₹1,218.9 crore (₹12,189 million).
Consolidated EBITDA (excluding other income) for 9M FY26 stood at ₹317 crore (₹3,170 million), a 12% increase from ₹282.6 crore (₹2,826 million) in 9M FY25. Q3 FY26 EBITDA saw a 20% increase, reaching ₹99.4 crore (₹994 million).
Profit After Tax (PAT) for 9M FY26 reported a significant 43% increase year-on-year to ₹196.8 crore (₹1,968 million), with a net margin of 16%. Q3 FY26 PAT increased by 16% to ₹52.8 crore (₹528 million), maintaining a PAT margin of 12.89%.
Operationally, the company improved its average occupancy levels from 62% in 9M FY25 to 65% in 9M FY26. Average Revenue Per Occupied Bed (ARPOB) also saw a steady improvement, increasing from ₹25,527 in 9M FY25 to ₹27,406 in 9M FY26.
Park Hospitals strategically expanded its footprint by acquiring Febris Multi-Speciality Hospital in New Delhi and KP Institute of Medical Sciences in Agra, adding a total of 560 beds to its network. The acquisition of KPIMS in Agra for ₹245 crore strengthens its presence in Uttar Pradesh, while the acquisition of Febris Hospital, a 200-bed facility, was completed through a 100% stake purchase via the IBC process.
These acquisitions align with the company's cluster-based expansion strategy, aiming to reach a total capacity of 5,260 beds by March 2028. Dr. Ankit Gupta, Chairman and Managing Director, commented that the performance was characterized by steady operational execution and continued growth strategy, with a focus on seamless integration of acquired assets and driving sustainable profitability.
What to do with a filing like this
Park Medi World Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Park Medi World Limited. Read the original for the full detail.